Shengsong Tang
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Immunology top 10%
- Immunotherapy and Immune Responses 7
- Immune cells in cancer 6
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 7
- RNA modifications and cancer 5
- Cell death mechanisms and regulation 4
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 5
Shengsong Tang
50 papers receiving 1000 citations
Peers
Comparison fields: 5 of 105
- Cancer Research 197
- Immunology 233
- Molecular Biology 519
- Biomaterials 98
- Oncology 203
Countries citing papers authored by Shengsong Tang
This map shows the geographic impact of Shengsong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengsong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengsong Tang more than expected).
Fields of papers citing papers by Shengsong Tang
This network shows the impact of papers produced by Shengsong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengsong Tang. The network helps show where Shengsong Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengsong Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 33 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 41 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 44 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 122 | |
| 14 | 2014 | 42 | |
| 15 | Progress in ROS-mediated JNK signaling pathway. | 2010 | 1 |
| 16 | Tissue distribution and physiological function of NOX family NADPH oxidases | 2008 | 1 |
| 17 | 2007 | 23 | |
| 18 | 2007 | 30 | |
| 19 | Mcm7——An Multifunctional Minichromosome Maintenance Protein | 2006 | 0 |
| 20 | 2006 | 8 |
About Shengsong Tang
Shengsong Tang is a scholar working on Immunology, Biological Psychiatry and Cancer Research, having authored 53 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Immune cells in cancer (6 papers), MicroRNA in disease regulation (5 papers), Nanoparticle-Based Drug Delivery (5 papers), RNA modifications and cancer (5 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Cancer Research (197 citations), Immunology (233 citations) and Molecular Biology (519 citations). Shengsong Tang has collaborated with scholars based in China and United States. Frequent co-authors include Qian Ning, Zhongcheng Mo, Xiaoyong Lei, Bing‐Yang Zhu, Sha Tang, Duan‐Fang Liao, Hongmei Luo, Wenjie Feng, Aimin Yang and Gavin Y. Wang. Their work appears in journals such as International Immunopharmacology, Acta Biochimica et Biophysica Sinica, Carcinogenesis, International Journal of Oncology and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.